Warhammer Survivors launches Nov 10 and it's a familiar vampire slayer grind for everyone. This marks a great expansion of the genre on mobile and Nintendo consoles to give official access to platforms that may not have had it. The low price is a great way for players to dive in to get a taste of the gameplay mechanics.
Auroch Digital and Poncle release the vampire slayer game across seven platforms
It's brought to us by Warhammer Survivors devs Auroch Digital and Vampire Survivors developers Poncle. There are more than 40 champions you can play and over 75 weapons to try out. There's a lot of options right out of the gate with more than 40 champions and 75 weapons to try out and customize your character.
- Platforms: PC (Steam, GOG), PlayStation 5, Xbox Series X|S, Nintendo Switch, Nintendo Switch 2, iOS, Android
- Playable Characters: 40+
- Weapons: 75+
- Price: $7.99 / €7.49 / £6.39
- Introductory Discount: 10% off for first week
PC (Steam / GOG) and PlayStation 5 and Xbox Series X|S release. Not to mention it's going on Nintendo Switch and Nintendo Switch 2. Also iOS and Android. It's Steam Deck Verified for PC for smooth handheld gaming.
Base price is $7.99 but you get regional currency equivalents of 7.49 euros or 6.39 pounds. There's also a first week 10% introductory discount bringing the price to $7.19 in the US. Also it's in Xbox Game Pass day one giving more value for players with a subscription.
We've followed Warhammer Survivors pretty closely from Steam Deck Verified news and so much more. It's out now alongside other survivors games. There's plenty of survivor games to choose from on the major digital distribution platforms. Jump right into your campaign on all the available devices.
Source: Warhammer Survivors, NotebookCheck




Forty champions and seventy-five weapons is a lot to process. I am skipping the intro discount and waiting for a deeper sale. The genre is saturated.
seven dollars is a steal for this many assets. I will grab it on day one with the Xbox Game Pass benefit. It is worth the risk.